Titan Pharmaceuticals (TTNP)
NASDAQ:TTNP

Titan Pharmaceuticals Stock Analysis & Ratings

Titan Pharmaceuticals Stock Analysis Overview

Smart Score
N/A
Not Ranked
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.

Stock Chart

TTNP

TTNP Stock Stats

Previous Close$0.99
Open$0.98
Bid0.97 x 7
Ask1.03 x 627
Today’s Range$0.95 - $1.01
52-Week Range$0.97 - $4.61
Volume71.83K
Average Volume309.75K
Market Cap$9.71M
Beta0.74
P/E Ratio-0.1
EPS-7.41
Earnings DateApr 04, 2022

Company Description

Titan Pharmaceuticals

Titan Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in development of therapeutics for the treatment of medical disorders. Its products include Probuphine, Ropinirole Implant, and T3 Implant. The company was founded by Louis R. Bucalo in February 7, 1992 and is headquartered in South San Francisco, CA.
Sector
Healthcare
Industry
Biotechnology
CEO
Marc Rubin
Employees
12
Website
www.titanpharm.com
ISIN
US8883146065
Address
400 Oyster Point Boulevard, South San Francisco, CA, 94080, US

Financials


P/E Ratio Range

The price to earnings ratio. This is used by investors to assess a stock’s market price relative to its earnings.

TTNP FAQ

What was Titan Pharmaceuticals’s price range in the past 12 months?
Titan Pharmaceuticals lowest stock price was $0.97 and its highest was $4.61 in the past 12 months.
    What is Titan Pharmaceuticals’s market cap?
    Titan Pharmaceuticals’s market cap is $9.71M.
      What is Titan Pharmaceuticals’s price target?
      Currently, no data Available
      What do analysts say about Titan Pharmaceuticals?
      Not enough analysts have published a price target to provide an average price target.
      When is Titan Pharmaceuticals’s upcoming earnings report date?
      Titan Pharmaceuticals’s upcoming earnings report date is Apr 04, 2022 which is in 75 days.
        How were Titan Pharmaceuticals’s earnings last quarter?
        Titan Pharmaceuticals released its earnings results on Nov 15, 2021. The company reported -$0.194 earnings per share for the quarter, beating the consensus estimate of -$0.35 by $0.156.
          Is Titan Pharmaceuticals overvalued?
          According to Wall Street analysts Titan Pharmaceuticals’s price is currently Overvalued.
            Does Titan Pharmaceuticals pay dividends?
            Titan Pharmaceuticals does not currently pay dividends.
            What is Titan Pharmaceuticals’s EPS estimate?
            Titan Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Titan Pharmaceuticals have?
            Titan Pharmaceuticals has 9,910,000 shares outstanding.
              What happened to Titan Pharmaceuticals’s price movement after its last earnings report?
              Titan Pharmaceuticals reported an EPS of -$0.194 in its last earnings report, beating expectations of -$0.35. Following the earnings report the stock price went down -3.681%.
                Which hedge fund is a major shareholder of Titan Pharmaceuticals?
                Currently, no hedge funds are holding shares in TTNP

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis